Your browser doesn't support javascript.
loading
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Lorenzi, Martina; Ferro, Alessandra; Cecere, Fabiana; Scattolin, Daniela; Del Conte, Alessandro; Follador, Alessandro; Pilotto, Sara; Polo, Valentina; Santarpia, Mariacarmela; Chiari, Rita; Pavan, Alberto; Dal Maso, Alessandro; Da Ros, Valentina; Targato, Giada; Vari, Sabrina; Indraccolo, Stefano; Calabrese, Fiorella; Frega, Stefano; Bonanno, Laura; Conte, Pier Franco; Guarneri, Valentina; Pasello, Giulia.
Affiliation
  • Lorenzi M; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  • Ferro A; Division of Medical Oncology 2, Veneto Institute of Oncology - IRCCS, Padova, Italy.
  • Cecere F; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  • Scattolin D; Division of Medical Oncology 2, Veneto Institute of Oncology - IRCCS, Padova, Italy.
  • Del Conte A; Oncology 1, Regina Elena National Cancer Institute - IRCCS, Padova, Italy.
  • Follador A; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  • Pilotto S; Medical Oncology and Immunorelated Tumors, National Cancer Institute Centro di Riferimento Oncologico (CRO) - IRCCS, Aviano (PN), Italy.
  • Polo V; Department of Medical Oncology, Azienda Sanitaria Universitaria Integrata of Udine, Santa Maria della Misericordia Hospital, Udine, Italy.
  • Santarpia M; Oncology Department, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • Chiari R; Oncology Unit, Azienda Unità Locale Socio Sanitaria (AULSS 2) Marca Trevigiana, Ca' Foncello Hospital, Treviso, Italy.
  • Pavan A; Medical Oncology, Azienda Ospedaliera Policlinico Universitario "G. Martino," Messina, Italy.
  • Dal Maso A; Medical Oncology, AULSS 6 Euganea, South Padua Hospital, Monselice (PD), Italy.
  • Da Ros V; Medical Oncology, AULSS 6 Euganea, South Padua Hospital, Monselice (PD), Italy.
  • Targato G; Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.
  • Vari S; Division of Medical Oncology 2, Veneto Institute of Oncology - IRCCS, Padova, Italy.
  • Indraccolo S; Medical Oncology and Immunorelated Tumors, National Cancer Institute Centro di Riferimento Oncologico (CRO) - IRCCS, Aviano (PN), Italy.
  • Calabrese F; Department of Medical Oncology, Azienda Sanitaria Universitaria Integrata of Udine, Santa Maria della Misericordia Hospital, Udine, Italy.
  • Frega S; Oncology 1, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
  • Bonanno L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Conte PF; Cardiovascular Pathology Unit, Department of Cardio-Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  • Guarneri V; Division of Medical Oncology 2, Veneto Institute of Oncology - IRCCS, Padova, Italy.
  • Pasello G; Division of Medical Oncology 2, Veneto Institute of Oncology - IRCCS, Padova, Italy.
Oncologist ; 27(2): 87-e115, 2022 03 04.
Article in En | MEDLINE | ID: mdl-35641222
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Italy